Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-05

Clinical Trial Update: A Phase 3 Study of HS-20094 in Patients With T2DM [Phase 3]

View source ↗

Summary

This clinical trial update describes a Phase 3 study of HS-20094 in adults with Type 2 diabetes mellitus, which is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HS-20094

Snippet

Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd. | Conditions: Type 2 Diabetes | Phase 3 | Status: NOT_YET_RECRUITING